WILLIAM HOWARD: Open Payments
NPI 1134903701 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,148 in 64 payments from 16 companies in 2025. Trend: 2023 $53 · 2024 $679 · 2025 $1,148
Food & beverage: $1,148
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 14 | $219 |
| PFIZER INC. | 12 | $158 |
| Merck Sharp & Dohme LLC | 8 | $144 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 7 | $129 |
| BIOTRONIK INC. | 2 | $106 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $63 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $63 |
| AstraZeneca Pharmaceuticals LP | 3 | $54 |
| Alnylam Pharmaceuticals Inc. | 3 | $53 |
| Esperion Therapeutics, Inc. | 2 | $34 |
Products named: ELIQUIS, VERQUVO, LifeVest, CAMZYOS, Acticor 7 VR-T DX, JARDIANCE, Kerendia, FARXIGA.
Industry payments across KY — which companies pay providers there.
